Abstract: The present invention relates to compounds useful for treating disorders associated with abnormal blood glucose levels in mammals, such as Type I and Type II diabetes. The invention also relates to methods of making and using such compounds.
Type:
Grant
Filed:
September 26, 2001
Date of Patent:
March 23, 2004
Assignee:
Medical Research Counsel
Inventors:
Patricia Townsend Wade Cohen, Christopher George Armstrong, Martin John Doherty
Abstract: A confocal scanning optical microscope system wherein a dispersive optical device such as a prism separates an image from a restricted area of a specimen into a spread of images of differing wavelengths. Different parts of the spread of images are focused at respective beam-limiting apertures which are conjugate with one another, and the spectrally differing beams passing through the beam-limiting apertures pass to respective detectors.
Abstract: A method of obtaining evoked otoacoustic emission (EOAE) response data, wherein stimulus and response signals in the form of a maximum length sequence (MLS) are deconvolved immediately and the non-linear interaction components (NLTICs) in the response data are detected, preferably by cross-correlation of a stimulus sequence and a response sequence.